Understanding HIV infection through blood cell studies
Official title: Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
Run by National Institutes of Health Clinical Center (CC) · NCT00001281 · Data updated 2026-11-12
This study is testing how HIV affects the immune system by looking at blood samples from people living with the virus to better understand the disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 120 Years |
| Sex | All |
| Enrollment | 2419 (estimated) |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 2 sites (Washington D.C., District of Columbia and 1 other locations) |
| Status | Recruiting |
| Started | March 9, 1993 |
| Registry record updated | October 29, 2026 |
| Trial ID | NCT00001281 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older, both living with and without HIV, who meet specific health criteria.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or have active substance abuse issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the virologic and immunologic parameters of HIV infection and other immune deficiency diseases using human peripheral blood cells. The research aims to elucidate the pathogenic aspects of HIV in relation to immune regulation and dysregulation. Participants will provide blood samples for analysis, which will help in understanding the disease's pathogenesis. The study is crucial due to the lack of adequate animal models for HIV research.
Why it matters
Potential benefit: If successful, this research could lead to a better understanding of HIV pathogenesis, potentially informing new treatment strategies.
How similar studies have gone: Previous studies utilizing human blood cells for HIV research have shown promise, indicating that this approach is both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA: * 18 years of age or older. * Adequate venous access. * Have a blood pressure less than or equal to 180/100: pulse rate 50-100, unless a lower pulse rate is considered normal for the volunteer. * Have adequate blood counts (volunteers living with HIV: hemoglobin greater than or equal to 9.0 g/dL, platelets greater than or equal to 50,000; volunteers living without HIV: hemoglobin greater than or equal to 9.0 g/dL, platelets greater than or equal to 50,000 * Be willing and able to provide written informed consent on screening, comply with study requirements and procedures, and comply with clinic policies * Willingness to allow blood samples to be used for future studies of HIV infection/pathogenesis, and undergo hepatitis screening EXCLUSION CRITERIA: * Pregnant and/or breastfeeding females. * Active substance abuse or history of prior substance abuse that may interfere with protocol compliance or compromise volunteer safety.
Where it's running
-
National Institutes of Health Clinical Center
Bethesda, Maryland, United States Recruiting -
Washington Hospital Center
Washington D.C., District of Columbia, United States Completed
Study contacts
- Principal investigator: Susan L Moir, Ph.D. — National Institute of Allergy and Infectious Diseases (NIAID)
- Study coordinator: Catherine A Seamon, R.N.
- Email: cseamon@cc.nih.gov
- Phone: (301) 402-3481
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.
-
New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV
This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.
-
Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV
This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.
-
HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters
This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.
-
Stigma-reducing program to help women who use drugs stay in HIV care
This test checks whether a stigma-reduction program helps women living with HIV who use drugs stay engaged in HIV care in Ukraine.
-
Platelets and HIV Reservoirs: A look at how platelets might harbor HIV in people living with HIV
This observational study tests whether HIV can be found inside platelets in adults with suppressed HIV on therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.